396 related articles for article (PubMed ID: 17045772)
1. Biotransformation of letrozole in rat liver microsomes: effects of gender and tamoxifen.
Tao X; Piao H; Canney DJ; Borenstein MR; Nnane IP
J Pharm Biomed Anal; 2007 Feb; 43(3):1078-85. PubMed ID: 17045772
[TBL] [Abstract][Full Text] [Related]
2. The effect of tamoxifen on the pharmacokinetics of letrozole in female rats.
Tao X; Brodie AM; Nnane IP
Biopharm Drug Dispos; 2006 Oct; 27(7):335-44. PubMed ID: 16912967
[TBL] [Abstract][Full Text] [Related]
3. The aromatase inactivator 4-hydroxyandrostenedione (4-OH-A) inhibits tamoxifen metabolism by rat hepatic cytochrome P-450 3A: potential for drug-drug interaction of tamoxifen and 4-OH-A in combined anti-breast cancer therapy.
Dehal SS; Brodie AM; Kupfer D
Drug Metab Dispos; 1999 Mar; 27(3):389-94. PubMed ID: 10064571
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and metabolism of a cysteinyl leukotriene-1 receptor antagonist from the heterocyclic chromanol series in rats: in vitro-in vivo correlation, gender-related differences, isoform identification, and comparison with metabolism in human hepatic tissue.
Kuperman AV; Kalgutkar AS; Marfat A; Chambers RJ; Liston TE
Drug Metab Dispos; 2001 Nov; 29(11):1403-9. PubMed ID: 11602515
[TBL] [Abstract][Full Text] [Related]
5. Reduction in tamoxifen-induced CYP3A2 expression and DNA adducts using antisense technology.
Mahadevan B; Arora V; Schild LJ; Keshava C; Cate ML; Iversen PL; Poirier MC; Weston A; Pereira C; Baird WM
Mol Carcinog; 2006 Feb; 45(2):118-25. PubMed ID: 16329150
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the influence of modulation of P-glycoprotein by a multiple dosing regimen of tamoxifen on the pharmacokinetics and toxicodynamics of doxorubicin.
Darvari R; Boroujerdi M
Cancer Chemother Pharmacol; 2005 Nov; 56(5):497-509. PubMed ID: 15937726
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of letrozole in male and female rats: influence of complexation with hydroxybutenyl-beta cyclodextrin.
Wempe MF; Buchanan CM; Buchanan NL; Edgar KJ; Hanley GA; Ramsey MG; Skotty JS; Rice PJ
J Pharm Pharmacol; 2007 Jun; 59(6):795-802. PubMed ID: 17637172
[TBL] [Abstract][Full Text] [Related]
8. Acidic metabolites of tamoxifen. Aspects of formation and fate in the female rat.
Ruenitz PC; Bai X
Drug Metab Dispos; 1995 Sep; 23(9):993-8. PubMed ID: 8565791
[TBL] [Abstract][Full Text] [Related]
9. Evidence that the catechol 3,4-Dihydroxytamoxifen is a proximate intermediate to the reactive species binding covalently to proteins.
Dehal SS; Kupfer D
Cancer Res; 1996 Mar; 56(6):1283-90. PubMed ID: 8640815
[TBL] [Abstract][Full Text] [Related]
10. [Sex-difference on flutamide metabolism in rat liver microsomal cytochrome P450 1A2].
Wang HX; Li D; Xu CJ; Liu X
Yao Xue Xue Bao; 2002 Aug; 37(8):608-10. PubMed ID: 12567773
[TBL] [Abstract][Full Text] [Related]
11. Characterization of deltamethrin metabolism by rat plasma and liver microsomes.
Anand SS; Bruckner JV; Haines WT; Muralidhara S; Fisher JW; Padilla S
Toxicol Appl Pharmacol; 2006 Apr; 212(2):156-66. PubMed ID: 16169030
[TBL] [Abstract][Full Text] [Related]
12. In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: a comparison with human liver microsomes.
Quintieri L; Fantin M; Palatini P; De Martin S; Rosato A; Caruso M; Geroni C; Floreani M
Biochem Pharmacol; 2008 Sep; 76(6):784-95. PubMed ID: 18671948
[TBL] [Abstract][Full Text] [Related]
13. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation.
Oktay K; Buyuk E; Libertella N; Akar M; Rosenwaks Z
J Clin Oncol; 2005 Jul; 23(19):4347-53. PubMed ID: 15824416
[TBL] [Abstract][Full Text] [Related]
14. In vitro metabolism and inductive or inhibitive effect of DL111 on rat cytochrome P4501A enzyme.
Hu YZ; Yao TW
Chem Biol Interact; 2004 Mar; 147(2):109-17. PubMed ID: 15013813
[TBL] [Abstract][Full Text] [Related]
15. Gender difference in letrozole pharmacokinetics in rats.
Liu XD; Xie L; Zhong Y; Li CX
Acta Pharmacol Sin; 2000 Aug; 21(8):680-4. PubMed ID: 11501174
[TBL] [Abstract][Full Text] [Related]
16. Deactivation of anti-cancer drug letrozole to a carbinol metabolite by polymorphic cytochrome P450 2A6 in human liver microsomes.
Murai K; Yamazaki H; Nakagawa K; Kawai R; Kamataki T
Xenobiotica; 2009 Nov; 39(11):795-802. PubMed ID: 19845430
[TBL] [Abstract][Full Text] [Related]
17. [In vitro comparison of thienorphine metabolism in liver microsomes of human, Beagle dog and rat].
Deng JT; Zhuang XM; Li H
Yao Xue Xue Bao; 2010 Jan; 45(1):98-103. PubMed ID: 21351457
[TBL] [Abstract][Full Text] [Related]
18. Hepatic DNA adduct dosimetry in rats fed tamoxifen: a comparison of methods.
Schild LJ; Phillips DH; Osborne MR; Hewer A; Beland FA; Churchwell MI; Brown K; Gaskell M; Wright E; Poirier MC
Mutagenesis; 2005 Mar; 20(2):115-24. PubMed ID: 15755801
[TBL] [Abstract][Full Text] [Related]
19. The oxidative metabolism of hydralazine by rat liver microsomes.
LaCagnin LB; Colby HD; O'Donnell JP
Drug Metab Dispos; 1986; 14(5):549-54. PubMed ID: 2876860
[TBL] [Abstract][Full Text] [Related]
20. In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans.
Lang D; Freudenberger C; Weinz C
Drug Metab Dispos; 2009 May; 37(5):1046-55. PubMed ID: 19196846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
